Apricitabine
Apricitabine
Apricitabine (pronunciation: /æpriˈsɪtəbiːn/) is an antiretroviral drug used in the treatment of HIV infection. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs), which block a critical step in the replication of HIV, thereby inhibiting its growth.
Etymology
The term "Apricitabine" is derived from the Latin word 'apricus', meaning 'exposed to the sun', and 'tabine', a suffix commonly used in the naming of antiviral drugs. The name signifies the drug's ability to expose and inhibit the growth of the HIV virus.
Usage
Apricitabine is used in combination with other antiretroviral drugs to treat HIV infection. It is not a cure for HIV, but it can help to control the virus and slow the progression of the disease.
Side Effects
Common side effects of Apricitabine include nausea, vomiting, and diarrhea. Less common side effects can include pancreatitis, lactic acidosis, and hepatomegaly with steatosis.
Related Terms
- Antiretroviral therapy: The use of drugs to manage HIV infection.
- Nucleoside: A basic building block of DNA and RNA.
- Reverse transcriptase: An enzyme that HIV uses to replicate itself.
- Inhibitor: A substance that slows down or stops a chemical reaction.
External links
- Medical encyclopedia article on Apricitabine
- Wikipedia's article - Apricitabine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski